Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 88,250 shares at $62.75 ($5.6M) on 2020-02-10, disclosed to the SEC on 2020-02-12.
Open-market sale of $5.6M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.75 | 9,251 | $581K | 10.3% |
| 2 | $62.75 | 9,251 | $581K | 10.3% |
| 3 | $63.14 | 9,249 | $584K | 10.4% |
| 4 | $63.14 | 9,249 | $584K | 10.4% |
| 5 | $63.03 | 14,250 | $898K | 16.0% |
| 6 | $63.03 | 14,250 |
| $898K |
| 16.0% |
| 7 | $63.88 | 4,250 | $271K | 4.8% |
| 8 | $65.31 | 5,800 | $379K | 6.7% |
| 9 | $66.19 | 12,400 | $821K | 14.6% |
| 10 | $66.80 | 300 | $20K | 0.4% |
| Total | $63.64 avg | 88,250 | $5.6M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |